Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/12/2006 | CA2602611A1 Methods of producing proteins having triple-helix structure |
10/11/2006 | EP1710314A1 Humanized immunoglobulin reactive with alpha4beta7 integrin |
10/11/2006 | EP1710312A1 Plant-optimized polynucleotide encoding approximately 45 kDa pesticidal protein |
10/11/2006 | EP1710311A2 Antigenic polypeptides |
10/11/2006 | EP1710310A1 Novel serum type streptococcus mutans and utilization of the same |
10/11/2006 | EP1710308A1 Method of reinforcing antibody activity |
10/11/2006 | EP1710305A1 Fraction and antibody comprising guinea pig immunoglobulin e |
10/11/2006 | EP1710256A1 Human monoclonal antibodies to prostate specific membrane antigen |
10/11/2006 | EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
10/11/2006 | EP1710250A1 Method for preparing serum albumin through heat-treatment in presence of divalent cation |
10/11/2006 | EP1709180A2 Method for overproducing a specific recombinant protein with p. cinnabarinus monokaryotic strains |
10/11/2006 | EP1709168A1 Generation of specific adhesion in gram-negative bacteria by means of anchoring immunoglobulin single domains on their surface with autotransporters |
10/11/2006 | EP1708755A2 Transglutaminase mediated conjugation of peptides |
10/11/2006 | EP1708732A2 Synthetic hla binding peptide analogues and uses thereof |
10/11/2006 | EP1469741B1 A process for the extraction,purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent |
10/11/2006 | EP1364032B1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
10/11/2006 | EP1309604A4 Phage-dependent superproduction of biologically active protein and peptides |
10/11/2006 | EP1257573B1 New transcription factor carp-2 |
10/11/2006 | EP1210374B1 Human monoclonal antibodies to prostate specific membrane antigen |
10/11/2006 | EP1200583B1 Fabrication of beta-pleated sheet proteins with specific binding properties |
10/11/2006 | EP1147134B1 Novel potassium channels and genes encoding these potassium channels |
10/11/2006 | EP1092767B1 Serine protease-specific monoclonal antibody and utilization thereof |
10/11/2006 | EP1071792B1 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
10/11/2006 | EP0975765B1 Plant fatty acid epoxygenase genes and uses therefor |
10/11/2006 | EP0914448B1 Lipid kinase |
10/11/2006 | EP0896586B1 ErbB3 ANTIBODIES |
10/11/2006 | EP0804479B1 Method of treating diabetes mellitus using kgf |
10/11/2006 | EP0751782B1 Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone for enhancing fertility |
10/11/2006 | EP0668777B1 Prostate-specific membrane antigen |
10/11/2006 | EP0490972B2 Recombinant negative strand rna virus expression systems and vaccines |
10/11/2006 | CN1846000A HPV CD8+ T-cell epitopes |
10/11/2006 | CN1845995A Chimeric antigens for breaking host tolerance to foreign antigens |
10/11/2006 | CN1845992A Novel vector and utilization of the same |
10/11/2006 | CN1844407A Method for simultaneous production of ergosterol and glutathione by yeast fermentation |
10/11/2006 | CN1844406A Method for preparing antihypertensive peptides by using proteins in shrimps |
10/11/2006 | CN1844392A Recombinant human ciliary nerve trophic factor mutant and method for preparing same |
10/11/2006 | CN1844375A Hybridoma cell strain capable of excreting monoclonal antibody of human carboxylesterase 2 and monoclonal antibody of human carboxylesterase 2 |
10/11/2006 | CN1844151A Monoclonal antibody against human CD40 mutant molecule and its use |
10/11/2006 | CN1844150A Soluble human CD28 molecule detection kit and its use |
10/11/2006 | CN1844149A Monoclonal antibody against human 4-1BBL and its use |
10/11/2006 | CN1844147A Monoclonal antibody against human CD154 and its use |
10/11/2006 | CN1844146A Monoclonal antibody against human B7-1 molecule and its use |
10/11/2006 | CN1844145A Preparation and use of monoclonal antibody against human OX40L |
10/11/2006 | CN1279171C Use of fusion proteins whose N-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
10/11/2006 | CN1279168C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them |
10/11/2006 | CN1279059C Fc fusion protein of human granulocyte colony stimulin with enhanced bioactivity |
10/11/2006 | CN1279051C DNA sequence and encoded mammary-specific breast cancer protein |
10/10/2006 | US7119248 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
10/10/2006 | US7119174 AURORA-1/2 (AUR1/2) antibodies or fragments thereof; humanized monoclonal antibodies; hybridomas; immunoassay; for treatment of cancer and screening cell growth inhibitors |
10/10/2006 | US7119170 Administering a polypeptide; blood disorders |
10/10/2006 | US7119169 Comprises p65 binding polypeptide (RAI) for diagnosis and treatment of adult respiratory distress syndrome, asthma, allograft rejection, cancer and inflammatory/autoimmune/vasoreconstrictive diseases |
10/10/2006 | US7119166 Universal procedure for refolding recombinant proteins |
10/10/2006 | US7119165 Nogo receptor-mediated blockade of axonal growth |
10/10/2006 | US7118924 Severe combined immunodeficiency disease (SCID); immunotherapy of human diseases such as prostate cancer |
10/10/2006 | US7118914 Comprises high expression of peroxidase promoter within Agrobacterium host cell; for production of health foods |
10/10/2006 | US7118913 In vivo urea cycle enzyme genes, transformation for protein expression |
10/10/2006 | US7118903 Comprises genetically engineered protein for use in treatment and prevention of cancer, obesity, cardiac, vascular, neurologic and or aging disorders |
10/10/2006 | US7118891 Producing a crystalline and/or amorphous metabolite suspension by treating the broth with a coagulant and/or a flocculant; and separating the biomass from the broth |
10/10/2006 | US7118890 Antibodies to vertebrate delta proteins and fragments |
10/10/2006 | US7118888 Gene expression vaccine |
10/10/2006 | US7118887 Nucleic acid overexpressed in esophageal tumor, normal stomach and melanoma |
10/10/2006 | US7118886 Ese genes and proteins |
10/10/2006 | US7118884 Method for controlling metallophosphate precipitation in high cell density fermentations |
10/10/2006 | US7118883 Process for producing peptides by using in vitro transcription/translation system |
10/10/2006 | US7118874 Generation of immunogenic peptide mixture; obtain immunogenic eptitope sequences of a parasite, determine amino acid sequences, synthesizing peptide mixture, recover peptides |
10/10/2006 | US7118873 Polynucleotides encoding cellular transporters and methods of use thereof |
10/10/2006 | US7118866 Heterodimeric receptor libraries using phagemids |
10/10/2006 | US7118756 Recombinant protective protein from Streptococcus pneumoniae |
10/10/2006 | US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA |
10/10/2006 | US7118749 Transferrin receptor genes |
10/10/2006 | US7118744 Immunogenic compositions for induction of anti-tumor immunity |
10/10/2006 | US7118743 Bispecific molecules cross-linking ITIM and ITAM for therapy |
10/10/2006 | US7118742 Ligand for herpes simplex virus entry mediator and methods of use |
10/10/2006 | US7118741 synthetic bi-functional or cross-linker protein which is capable of binding to a molecular species, particularly a macromolecule such as an antibody; having a binding region capable of binding the to transcytosis receptors present in epithelial cells (such a mucosal cells) |
10/10/2006 | US7118737 Adjust pharmokinetics; ligation, binding, overlapping; nonimmunogenic; genetic engineering |
10/10/2006 | CA2212887C Monoclonal antibody specific for .beta.a4 peptide |
10/05/2006 | WO2006105486A2 Novel tumor suppressor gene and compositions and methods for making and using the same |
10/05/2006 | WO2006105483A2 Mutant dna polymerases and methods of use |
10/05/2006 | WO2006105426A2 Manufacturing process for the production of peptides grown in insect cell lines |
10/05/2006 | WO2006104536A2 Polynucleotides encoding stem cell factor-like proteins |
10/05/2006 | WO2006104186A1 Dipeptide crystal and method for producing same |
10/05/2006 | WO2006103494A2 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
10/05/2006 | WO2006103258A1 Method for improved isolation of recombinantly produced proteins |
10/05/2006 | WO2006102767A1 Tuberculosis vaccine and method for making same |
10/05/2006 | WO2006102722A1 Process for the production of ϝ-glutamylcysteine |
10/05/2006 | WO2006073422A9 Activation of natural killer (nk) cells and methods of use |
10/05/2006 | WO2006052754A3 Ammonium transporter promoter for gene expression in oleaginous yeast |
10/05/2006 | WO2006052591A3 Anti-properdin antibodies, and methods for making and using same |
10/05/2006 | WO2006044045A3 Cryptosporidium hominis genes and gene products for chemotherapeutic, immunoprophylactic and diagnostic applications |
10/05/2006 | WO2006014292A3 Oral vaccine for borrelia |
10/05/2006 | WO2006009901A3 Novel antigen-binding polypeptides and their uses |
10/05/2006 | WO2006005032A3 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
10/05/2006 | WO2005116233A3 Composition and method of cancer treatment |
10/05/2006 | WO2004022705A3 Neurotransmission-associated proteins |
10/05/2006 | WO2003087306A8 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
10/05/2006 | US20060223987 Neutrophil specific immunoglobulins for use in treatment and prevention of microbial infection |
10/05/2006 | US20060223983 Lipopeptide stereoisomers, methods for preparing same and useful intermediates |
10/05/2006 | US20060223772 Vectors comprising guinea pig CMV regulatory elements |
10/05/2006 | US20060223756 Endothelial cell specifically binding peptides |
10/05/2006 | US20060223755 biodrug having affinity to bacterial and fungal toxins, and especially to lipopolysaccharide or lipoteichoic acid; treating a fungal or bacterial infection; ear infection, upper respiratory infection, sinusitis, otitis |